Huntsman (HUN) Q4 2025 earnings review
Pricing Pressure Crushes Profitability
Huntsman ended FY25 with a difficult quarter, as weak demand and pricing pressures drove Adjusted EBITDA down 51% YoY to just $35 million. Despite a 2% volume increase in Polyurethanes, aggressive pricing competition (ASP down 11%) decimated the segment's earnings. The company posted an Adjusted Net Loss of $63 million ($0.37/share), worsening from a $43 million loss a year ago. While management generated $20 million in free cash flow through discipline, the narrative of 'stabilization' is challenged by the sequential EBITDA collapse from $94 million in Q3 to $35 million in Q4.
🐂 Bull Case
Despite reporting a net loss, Huntsman generated $20M in Free Cash Flow in Q4 and $125M for the full year. Restructuring efforts and tight CapEx control are preserving the balance sheet (~$1.3B liquidity) during the trough.
Polyurethanes sales volumes actually grew 2% YoY in Q4 (and +1% YoY in Q3). If pricing power returns, the operating leverage on these volumes could drive a sharp recovery.
🐻 Bear Case
The company is sacrificing price for volume. In Polyurethanes, a 2% volume gain cost them 11% in pricing. This trade-off resulted in a 50% collapse in segment EBITDA.
Adjusted Net Loss widened to $63M from $43M a year ago. With an effective tax rate of -1% and persistent negative operating leverage, the path to GAAP profitability looks distant without a major macro turn.
⚖️ Verdict: 🔴
Bearish. While the company is surviving via cash management, the Q4 earnings collapse indicates that the cycle bottom has not been established. The inability to hold pricing in Polyurethanes is a major red flag.
Key Themes
Polyurethanes Profitability Collapse
The Polyurethanes segment, typically the core driver, saw Adjusted EBITDA halve to $25 million (from $50 million in 24Q4). While volumes rose 2%, average selling prices fell 11% due to 'less favorable supply and demand dynamics.' This suggests intense competitive pressure where Huntsman is buying volume at the expense of margins.
Performance Products Margins Compressing
Performance Products EBITDA fell 30% YoY to $16 million. The company cited 'competitive pressures' driving lower selling prices (-6%) and an unfavorable impact from reduced inventory. This segment has decelerated sequentially from $29M in Q3 to $16M in Q4.
Advanced Materials Resilience
Advanced Materials remains the most stable segment. While Revenue fell 4% YoY, Adjusted EBITDA held relatively firm at $36 million (vs $37 million YoY). Pricing power remains intact here (+1% ASP), unlike the commodity-exposed segments, though volumes softened (-7%).
Capital Preservation Mode
Management continues to prioritize cash. Full year 2025 Free Cash Flow was $125 million, up from $101 million in 2024, despite the massive drop in profitability. This was achieved by keeping CapEx below depreciation ($173M spend vs ~$287M D&A) and managing working capital.
Other KPIs
Decelerating/Negative. The loss widened significantly from $(0.25) in 24Q4 and $(0.03) in 25Q3. The efficiency of cost cuts is being overwhelmed by pricing deflation.
Decelerating. Down 7% YoY and down 7% sequentially from Q3 ($1,460M). The decline is driven primarily by price deflation (-8% aggregate) rather than volume (-0% aggregate volume/mix).
Compressing. Down from 4.9% in 24Q4 and 6.4% in 25Q3. The 2.6% margin indicates the company is operating dangerously close to breakeven on a cash basis before interest and tax.
Guidance
Stable. Management expects 'similar capital expenditure levels as to the 2025 year' (which was $173M). This implies a maintenance-mode budget, well below the ~$287M annual depreciation run rate, aimed at preserving cash.
Management remains cautious, stating 'meaningful changes may not occur in the immediate term.' They remain confident the cycle will 'eventually improve' but are not forecasting a near-term snapback.
Key Questions
Polyurethanes Pricing Floor
ASP in Polyurethanes dropped 11% YoY. Is this purely raw material pass-through, or are we seeing structural margin degradation to defend market share against Chinese competitors?
Q4 EBITDA Collapse
EBITDA fell from $94M in Q3 to $35M in Q4. How much of this was normal seasonality versus a sudden deterioration in December orders?
Cash Burn vs Dividend
With the dividend reset in Q3, and current FCF at $20M for the quarter, is the current capital allocation sustainable if 2026 EBITDA mirrors 2025?